The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 2.94 — safe zoneOK
- Earnings-manipulation signal · Beneish M -15.39 — no flag raisedOK
- Earnings quality 81/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as RETRACTABLE TECHNOLOGIES INC reports it. History and quarterly detail are in the app.
- Syringes$24.9M
- Easy Point Needles$11.9M
- Blood Collection Products$1.4M
- Other Products$44K
Latest filings
- 10-Q · Quarterly report2026-05-15
- 8-K · Company announcement2026-05-15
- 8-K · Company announcement2026-05-13
- 8-K · Company announcement2026-04-10
- DEF 14A · Annual proxy (pay & governance)2026-03-27
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about RETRACTABLE TECHNOLOGIES INC, every answer cited🔒
- The Intelligence Brief — added when RETRACTABLE TECHNOLOGIES INC's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.